Earnings History Data for Corbus Pharmaceuticals Holdings, Inc. (CRBP) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
06-08-2024	PM		CRBP	Corbus Pharmaceuticals	606.00	-0.90	-1.16	0.00	Corbus Pharmaceuticals GAAP EPS of -$0.90 [8/6/2024 9:08 AM]	53.00	-2.03 (-3.69%)	56.80	1.77 (3.22%)	3.03 - 61.90	386,399	230,000	791
Corbus Pharmaceuticals GAAP EPS of -$0.90 [8/6/2024 9:08 AM]
07-05-2024	PM		CRBP	Corbus Pharmaceuticals	407.00	-0.83	-1.09	0.00	Corbus Pharmaceuticals EPS of -$0.83 beats by $0.26 [5/7/2024 1:13 PM]	39.80	0.98 (2.52%)	0.0	0.0 (0.00%)	3.03 - 49.87	144,015	180,000	0
Corbus Pharmaceuticals EPS of -$0.83 beats by $0.26 [5/7/2024 1:13 PM]
07-11-2023	PM		CRBP	Corbus Pharmaceuticals	23.00	-2.27	-2.06	0.00	Corbus Pharmaceuticals GAAP EPS of -$2.27 misses by $0.21 [11/7/2023 9:51 AM]	4.16	-0.88 (-17.46%)	0.0	0.0 (0.00%)	2.11 - 13.17	35,107	10,000	0
Corbus Pharmaceuticals GAAP EPS of -$2.27 misses by $0.21 [11/7/2023 9:51 AM]
07-03-2023	PM	8:05 AM ET (Mar 7)	CRBP	Corbus Pharmaceuticals	12.00	-2.61	-2.10	0.00		2.70	-0.15 (-5.26%)	2.92	0.07 (2.46%)	2.62 - 18.72	72,673	70,000	2,029

08-11-2022	PM		CRBP	Corbus Pharmaceuticals	16.00	-0.07	-0.06	0.00	Corbus Pharmaceuticals GAAP EPS of -$0.07 misses by $0.01 [11/8/2022 8:44 AM]	0.1275	0.0 (-1.92%)	0.13	0.0 (0.00%)	0.10 - 1.11	387,219	2,450,000	127,513
Corbus Pharmaceuticals GAAP EPS of -$0.07 misses by $0.01 [11/8/2022 8:44 AM] Corbus Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update [Nov-08-22 08:05AM]
09-08-2022	PM	8:00 AM ET (Aug 9)	CRBP	Corbus Pharmaceuticals	33.00	-0.07	-0.06	0.00	Corbus Pharmaceuticals GAAP EPS of -$0.11 [8/9/2022 8:27 AM]	0.2551	-0.01 (-4.46%)	0.28	0.01 (3.90%)	0.21 - 1.42	484,578	410,000	14,634
Corbus Pharmaceuticals GAAP EPS of -$0.11 [8/9/2022 8:27 AM]
10-05-2022	PM		CRBP	Corbus Pharmaceuticals	37.00	-0.08	-0.09	0.00	Corbus Pharmaceuticals GAAP EPS of -$0.08 beats by $0.01 [5/10/2022 8:40 AM]	0.2581	-0.01 (-2.64%)	0.28	0.01 (3.92%)	0.26 - 2.29	555,774	1,083,351	18,696
Corbus Pharmaceuticals GAAP EPS of -$0.08 beats by $0.01 [5/10/2022 8:40 AM] Corbus Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update [May-10-22 08:00AM] Corbus Pharmaceuticals (CRBP) Reports Q1 Loss, Lags Revenue Estimates [May-10-22 09:25AM]
08-03-2022	PM		CRBP	Corbus Pharmaceuticals	42.00	-0.08	-0.11	0.00	Corbus Pharmaceuticals GAAP EPS of -$0.37 beats by $0.03, revenue of $0.88M beats by $0.04M [3/8/2022 8:26 AM]	0.3377	0.02 (6.36%)	0.0	0.0 (0.00%)	0.30 - 2.46	383,667	980,000	0
Corbus Pharmaceuticals GAAP EPS of -$0.37 beats by $0.03, revenue of $0.88M beats by $0.04M [3/8/2022 8:26 AM] Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Updates [Mar-08-22 08:05AM] Aquestive Therapeutics (AQST) Reports Q4 Loss, Tops Revenue Estimates [Mar-08-22 06:15PM]
12-11-2021	PM		CRBP	Corbus Pharmaceuticals	125.00	-0.02	-0.12	0.00	Corbus Pharmaceuticals EPS beats by $0.10, misses on revenue [11/12/2021 8:18 AM]	1.07	0.02 (1.43%)	0.0	0.0 (0.00%)	0.95 - 4.00	1,925,478	1,350,000	0
Corbus Pharmaceuticals EPS beats by $0.10, misses on revenue [11/12/2021 8:18 AM] Corbus Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Updates [Nov-12-21 08:05AM] Corbus Pharmaceuticals to Present at the Jefferies London Healthcare Conference [Nov-11-21 08:05AM]
15-03-2021	PM	7:05 AM ET (Mar 15)	CRBP	Corbus Pharmaceuticals Holdings, Inc.	157.15	-0.10	-0.31	-0.41	Corbus Pharmaceuticals EPS beats by $0.13, misses on revenue [3/15/2021 7:08 AM]	2.26	-0.06 (-2.79%)	2.38	0.05 (2.15%)	0.91 - 9.78	8,774,722	7,972,277	355,513
Corbus Pharmaceuticals EPS beats by $0.13, misses on revenue [3/15/2021 7:08 AM] Corbus hints at potential pipeline expansion deals, shares rise [3/15/2021 7:42 AM] Corbus Pharmaceuticals Holdings, Inc. to Host Earnings Call [Mar-15-21 06:30AM] Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2020 Financial Results [Mar-15-21 07:05AM] Recap: Corbus Pharmaceuticals Q4 Earnings [Mar-15-21 08:26AM] Corbus Pharmaceuticals Holdings, Inc. (CRBP) Q4 2020 Earnings Call Transcript [Mar-15-21 02:30PM]
10-11-2020	PM	7:05 AM ET (Nov 10)	CRBP	Corbus Pharmaceuticals Holdings, Inc.	92.33	-0.43	-0.41	-0.32	Corbus Pharmaceuticals EPS misses by $0.02, misses on revenue [11/10/2020 7:08 AM]	1.22	0.0 (-0.41%)	1.17	-0.05 (-4.10%)	0.91 - 9.78	4,445,958	2,796,468	52,930

06-08-2020	PM	7:05 AM ET (Aug 6)	CRBP	Corbus Pharmaceuticals Holdings, Inc.	492.21	-0.52	-0.38	0.03	Corbus Pharmaceuticals EPS misses by $0.14, misses on revenue [8/6/2020 7:08 AM]	6.40	-0.75 (-10.49%)	7.10	-0.05 (-0.70%)	3.29 - 8.78	1,527,415	1,786,776	14,199